Plasma BACE1 concentration is a novel core candidate biomarker potentially serving for different context(s) of use to enrich both clinical diagnostic-prognostic workup and pharmacological trials for early Aβ-targeted therapies for AD. To investigate the question whether and how BACE1 expression levels (reflected by plasma concentrations) are…
Home Alzheimer's Research Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in...